ADVENTRIS PHARMACEUTICALS
Adventris Pharmaceuticals is a pharmaceutical company that develops cancer vaccines.
ADVENTRIS PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2022-01-01
Address:
San Francisco, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
500 K USD
Similar Organizations
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Lyell Immunopharma
Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer.
Mirum Pharmaceuticals
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Current Employees Featured
Founder
Investors List
Y Combinator
Y Combinator investment in Pre Seed Round - Adventris Pharmaceuticals
More informations about "Adventris Pharmaceuticals"
Adventris Pharmaceuticals
Adventris Pharmaceuticals is a biotechnology company focusing on cancer immunotherapy. Skip to main content Adventris is a biotechnology company focusing on cancer immunotherapy. For …See details»
Adventris Pharmaceuticals - Crunchbase Company …
Adventris Pharmaceuticals closed its last funding round on Apr 5, 2023 from a Pre-Seed round. Who are Adventris Pharmaceuticals 's competitors? Alternatives and possible competitors to Adventris Pharmaceuticals may include Carisma …See details»
Adventris Pharmaceuticals - Y Combinator
Jen Herbach is the CEO of Adventris Pharmaceuticals. She has more than a decade of biotech industry experience bringing novel oncology drugs to market, across companies including …See details»
Adventris Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Nov 18, 2024 Explore Adventris Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Adventris Pharmaceuticals - Funding, Financials, Valuation
Adventris Pharmaceuticals is a pharmaceutical company that develops cancer vaccines. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. ...See details»
Adventris Pharmaceuticals - PitchBook
Adventris Pharmaceuticals General Information Description. Operator of a biotechnology company intended to focus on cancer immunotherapy treatments. The company develops cancer vaccines by teaching the body's immune …See details»
Pre Seed Round - Adventris Pharmaceuticals - Crunchbase
Apr 5, 2023 Adventris Pharmaceuticals raised $500000 on 2023-04-05 in Pre Seed Round. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. …See details»
Adventris Pharmaceuticals - LinkedIn
CEO & Co-Founder, Adventris Pharmaceuticals Zeal Kamdar Ph.D. candidate in Cellular and Molecular Medicine at The Johns Hopkins UniversitySee details»
Adventris Pharmaceuticals - VentureRadar
Similar Companies: Argobio France Privately Held Launched in 2021, Argobio will create and launch at least five ambitious biotech companies over the next five years sourcing innovative …See details»
Adventris Pharmaceuticals - Products, Competitors, Financials ...
Apr 10, 2023 Adventris Pharmaceuticals: Adventris makes cancer vaccines “Adventris makes cancer vaccines. By teaching our body’s immune system to recognize and kill the drivers of …See details»
ADVENTRIS PHARMACEUTICALS, INC. - Bizapedia
Sep 16, 2024 ADVENTRIS PHARMACEUTICALS, INC. is a California Stock Corporation - Out Of State - Stock filed on September 9, 2024. The company's filing status is listed as Active and …See details»
Adventris - Company Profile - Tracxn
Nov 10, 2023 Competitive landscape of Adventris. Adventris has 460 active competitors and it ranks 213th among them.; 129 of its competitors are funded while 108 have exited. Overall, …See details»
Adventris Pharmaceuticals | Founders and Board of Directors
List of Founders and Board of members of Adventris Pharmaceuticals Toggle navigation. Solutions. By Investment Industry. Venture Capital Funds Private Equity Funds Accelerators & …See details»
Adventris Pharmaceuticals - Contacts, Employees, Board Members ...
Adventris Pharmaceuticals is a pharmaceutical company that develops cancer vaccines.See details»
Adventris Pharmaceuticals Stock Price, Funding, Valuation, …
See Adventris Pharmaceuticals funding rounds, investors, investments, exits and more. Evaluate their financials based on Adventris Pharmaceuticals's post-money valuation and revenue.See details»
Jenny Herbach Profile: Contact Information & Network - PitchBook
Jenny Herbach General Information Biography. Ms. Jen Herbach is a Co-Founder & serves as Chief Executive Officer at Adventris Pharmaceuticals. She has more than a decade of biotech …See details»
Immunotherapy Before Surgery May Improve Outcomes for …
Aug 22, 2024 Yarchoan is a co-founder with equity of Adventris Pharmaceuticals; has received consulting fees from AstraZeneca, Exelixis, Genentech, Replimune, Hepion, and Lantheus; …See details»
Adventris Pharmaceuticals Pitch - YouTube
Nov 20, 2024 Adventris’ vaccine platform enables us to make “off the shelf" cancer vaccines targeting the most common oncogenes, for the treatment and prevention of cance...See details»
Jenny Lesser Herbach - CEO & Co-Founder @ Adventris …
Primary Organization . Adventris Pharmaceuticals . Location San Francisco, California, United States; Regions San Francisco ... Number of Current Jobs 1. Jenny Lesser Herbach is the …See details»
Neoadjuvant immunotherapy yields comparable outcomes in high …
Aug 15, 2024 Yarchoan is a co-founder with equity of Adventris Pharmaceuticals; has received consulting fees from AstraZeneca, Exelixis, Genentech, Replimune, Hepion, and Lantheus; …See details»